Research Article
Controlled Release Bilayer Floating Effervescent and Noneffervescent Tablets Containing Levofloxacin and Famotidine
Table 8
The stability parameters of drug and dosage form in optimized selected formulations.
| Parameters | F2 | F5 | F2 | F5 | F2 | F5 |
| Time (days) | After 30 days | After 60 days | After 90 days | Appearance | No changes | No change | No change | No change | No change | No change | Hardness (kg/cm2) | | | | | | | Weight variation (mg) | | | | | | | Drug contents of levofloxacin (%) | | | | | | | Drug content of famotidine (%) | | | | | | | Floating lag time (second) | | | | | | | Total floating time (hours) | | | | | | | Swelling index (8 hours) | | | | | | | Erosion (%) (24 hours) | | | | | | |
|
|